Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 9;12(1):5992.
doi: 10.1038/s41598-022-08553-x.

Phenanthrene-enriched extract from Eulophia macrobulbon using subcritical dimethyl ether for phosphodiesterase-5A1 inhibition

Affiliations

Phenanthrene-enriched extract from Eulophia macrobulbon using subcritical dimethyl ether for phosphodiesterase-5A1 inhibition

Jukkarin Srivilai et al. Sci Rep. .

Abstract

Eulophia macrobulbon (E.C.Parish & Rchb.f.) Hook.f. contains a natural PDE5A1 inhibitor, phenanthrene, 1-(4'-hydroxybenzyl)-4,8- dimethoxyphenanthrene-2,7-diol (HDP), a potential agent for the treatment of erectile dysfunction. The aim of this study was to improve the extraction efficiency of HDP from E. macrobulbon by using a more environmentally friendly extraction method, subcritical liquid dimethyl ether extraction (sDME), instead of classical solvent extraction (CSE) and ultrasound-assisted extraction (UAE). The efficiency and quality of the extracts obtained were evaluated using the following criteria: %process yield; solvent amount; extraction time; temperature; %HDP content by LC-MS, bioactivity as inhibition of phosphodiesterase-5A1 (PDE5A1) by radio-enzymatic assay; and chemical profiles by LC-QTOF-MS. sDME provided the highest content of HDP in the extract at 4.47%, much higher than the use of ethanol (0.4-0.5%), ethyl acetate (1.2-1.7%), or dichloromethane (0.7-1.4%). The process yield for sDME (1.5-2.7%) was similar to or lower than the other solvents (0.9-17%), but as long as the process yield is not prohibitively low, the concentration is a more important measure for clinical use. The optimal conditions for sDME extraction were: Extraction time, 40 min; 200% water as co-solvent; sample-to-solvent ratio of 1:8; temperature, 35 °C. Phenanthrene aglycone and glycoside derivatives were the major constituents of the sDME extracts and lesser amounts of phenolic compounds and sugars. The inhibition of PDE5A1 by sDME (IC50 0.67 ± 0.22 µg/ml) was tenfold more potent than ethanolic extract and other extraction methods, suggesting a high probability of clinical efficacy. Thus, sDME was a more efficient, faster, solvent-saving and environmentally friendly extraction method and more selective for phenanthrene when extracted from E. macrobulbon.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Parameters influencing dimethyl ether (sDME) extraction of E. Macrobulbon root powder as total yield (black bars) and its content of the bioactive ingredient, HDP measured LC/MS (open bars). Values deemed optimal for each parameter were used for the next parameter measures (b–e) which were (a) sDME volume (1:8), (b) (40 min extraction period), and (c) (35 °C). Each bar is a single determinations.
Figure 2
Figure 2
Total ion count LC–MS chromatograms (TIC) from of sample extracts of E. macrobulbon with 50 µg/ml. All chromatograms have the same y-scales but only A and D scales shown. The numbered peaks correspond with compounds identified in Table 2. Extraction protocols were: (A) 10 g water added 5 g powdered E. Macrobulbon root and extracted with 40 g DME (method of sample no. 31, Table 1); (B) cDCM, method of sample no. 3 (Table 1); (C) cEtOAc, method of sample no. 12 (Table 1), (D) cEtOH, method of sample no. 12 (Table 1).
Figure 3
Figure 3
Identifiable compounds of aglycone phrenanthrene structure from E. Macrobulbon root extract using LC-QTOF-MS.

Similar articles

References

    1. McCabe MP, et al. Definitions of sexual dysfunctions in women and men: A consensus statement from the fourth International Consultation on Sexual Medicine 2015. J. Sex. Med. 2016;13:135–143. doi: 10.1016/j.jsxm.2015.12.019. - DOI - PubMed
    1. Hatzimouratidis K, et al. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur. Urol. 2010;57:804–814. doi: 10.1016/j.eururo.2010.02.020. - DOI - PubMed
    1. Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int. J. Impot. Res. 2004;16:S4–S7. doi: 10.1038/sj.ijir.3901205. - DOI - PubMed
    1. Peak TC, Kammel K, Sangkum P, Tan RBW, Hellstrom WJG. Reference Module in Biomedical Sciences. Elsevier; 2015.
    1. Boyce EG, Umland EM. Sildenafil citrate: A therapeutic update. Clin. Ther. 2001;23:2–23. doi: 10.1016/S0149-2918(01)80027-8. - DOI - PubMed

Publication types